[1]
M. F. Vallejos Paredes, “Analysis of the cellular viability and migratory capacity of triple-negative breast cancer cells stimulated with doxorubicin used during neoadjuvant chemotherapy”, LACCEI, vol. 1, no. 14, July 2026, doi: 10.18687/LACCEI2026.1.1.1479.